Hepatic conversion of angiotensin I and the portal hypertensive response to angiotensin II in normal and regenerating liver

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 9, 2007, Pages 1543-1548

  Carvalho, Leda Teixeira ^a   Nascimento, Écio Alves ^b   Teixeira, Felipe Oliveira ^a   Nagaoka, Márcia Regina ^a   Borges, Durval Rosa ^a   Kouyoumdjian, Maria ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c Experimental Hepatology Laboratory UNIFESP ^*  (Brazil)

Author keywords

Angiotensin; Angiotensin coverting enzyme; Bradykinin; Liver perfusion; Liver regeneration

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN[1-7]; CAPTOPRIL; LOSARTAN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; LIVER METABOLISM; LIVER PERFUSION; LIVER REGENERATION; LIVER RESECTION; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT;

EID: 34547968607     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05074.x     Document Type: Article

References (27)

1. Borges DR, Limãos EA, Prado JL, Camargo ACM. Catabolism of vasoactive polypeptides by perfused rat liver. Naunyn Schmiedebergs Arch. Pharmacol. 1976 295 : 33 40.
2. Molina HM, Carmona AK, Kouyoumdjian M, Borges DR. Thimet oligopeptidase EC 3.4.24.15 is a major liver kininase. Life Sci. 2000 67 : 509 20.
3. Gioli-Pereira L, Nascimento EA, Santos EL et al. Fate of bradykinin on the rat liver when administered by the venous or arterial route. J. Gastroenterol. Hepatol. 2005 20 : 463 73.
4. Nascimento EA, Gioli-Pereira L, Carvalho LT et al. Hemodynamic and metabolic effects of angiotensin II on the liver. Peptides 2005 26 : 315 22.
5. Clauser E, Curnow KM, Davies E et al. Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur. J. Endocrinol. 1996 134 : 403 11.
6. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 2002 13 : 336 43.
7. Henriksen EJ, Jacob S. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J. Cell. Physiol. 2003 196 : 171 9.
8. Timmermans PB. Pharmacological properties of angiotensin II receptor antagonists. Can. J. Cardiol. 1999 15 (Suppl. F 26F 28F.
9. Blohoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J. 1991 5 : 271 7.
10. Santos RAS, Campagnole-Santos MJ, Andrade SP. Angiotensin-(1-7): an update. Regul. Pept. 2000 91 : 45 62.
11. Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin. Liver Dis. 2001 21 : 337 49.
12. Li D, Friedman SL. Hepatic stellate cells: morphology, function, and regulation. In : Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz DA, eds. The Liver, Biology and Pathobiology, 4th edn. Philadelphia, PA : Lippinott, 2001 455 68.
13. Mabuchi A, Mullaney I, Sheard PW et al. Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J. Hepatol. 2004 40 : 910 16.
14. Abdussalam M. International Guiding Principles for Biomedical Research Involving Animal by the Council for International Organizations of Medical Sciences (CIOMS). Geneva : Council for International Organizations of Medical Sciences (CIOMS), 1985 1 28.
15. Borges DR, Kouyoumdjian M. The recognition factor for clearance of plasma kallikrein is located on its heavy chain and not exposed on prokallikrein. J. Hepatol. 1992 16 : 115 21.
16. Suzuki-Kemmelmeier F, Ishii-Iwamoto EL, Bracht A. Metabolism of fructose in the bivascularly perfused rat liver. Biochim. Biophys. Acta 1992 1116 : 275 82.
17. Carlini EA, Picarelli ZP, Prado JL. Pharmacological activity of hypertensin I and its conversion into hypertensin II. Bull. Soc. Chim. Biol. (Paris) 1958 40 : 1825 34.
18. Ng KK, Vane JR. Conversion of angiotensin I to angiotensin II. Nature 1967 216 : 762 6.
19. de Lannoy LM, Danser AH, Bouhuizen AM, Saxena PR, Schalekamp MA. Localization and production of angiotensin II in the isolated perfused rat heart. Hypertension 1998 31 : 1111 17.
20. Lancien F, Mimassi N, Mabin D, Mével JCL. Captopril blocks the cardiac actions of centrally administered angiotensin I in the trout Oncorhynchus mykiss. Brain Res. 2004 1007 : 116 23.
21. Lawrence AC, Evin G, Kladis A, Campbell DJ. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J. Hypertens. 1990 8 : 715 24.
22. Bataller R, Ginès P, Nicolás JM et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000 118 : 1149 56.
23. Bataller R, Sancho-Bru P, Ginès P et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 2003 125 : 117 25.
24. Bataller R, Sancho-Bru P, Gines P, Brenner DA. Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid. Redox Signal. 2005 7 : 1346 55.
25. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 2000 275 : 2247 50.
26. Sherman IA, Dlugosz JA, Barker F, Sadeghi FM, Pang KS. Dynamics of arterial and portal venous flow interactions in perfused rat liver: an intravital microscopic study. Am. J. Physiol. 1996 271 : G201 10.
27. Constantin J, Ishii-Iwamoto EL, Suzuki-Kemmelmeier F, Yamamoto NS, Bracht A. The action of glucagon infused via the hepatic artery in anterograde and retrograde perfusion of the rat liver is not a function of the accessible cellular spaces. Biochim. Biophys. Acta 1995 1244 : 169 78.